University of California, Los Angeles

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of California, Los Angeles sits in the top decile of US sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count).

897 total trials 158 currently recruiting 622 completed early-phase tilt top decile by trial count

University of California, Los Angeles: 897 sponsored US clinical trials, 158 recruiting.

University of California, Los Angeles sponsors 897 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 622 completed. 98 of these trials are in Phase 3-4 (later-stage) and 194 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.

Top-decile sponsor footprint

University of California, Los Angeles ranks in the top decile of sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 69/100

622 of 679 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

897 total, page 8 of 18

COMPLETED NA

Patient Decision Aid for Opioid Use Disorder

NCT03568552

COMPLETED

Blood Brain Barrier Dysfunction and Postoperative Neurocognitive Disorders

NCT04566562

COMPLETED NA

Percutaneous Electrical Nerve Field Stimulation for Adults With Irritable Bowel Syndrome

NCT04428619

TERMINATED NA

Testing of a Navigation Intervention for Hepatitis C and HIV

NCT04499651

COMPLETED NA

Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance

NCT04459520

COMPLETED NA

Postoperative Opt-In Narcotic Treatment Study

NCT04710069

COMPLETED NA

A Mobile Phone Based Pilot Intervention to Prevent Obesity in Latino Preschool Children

NCT04261985

TERMINATED NA

Treatment of Anterior Blepharitis With Microblepharoexfoliation Procedure

NCT04290455

COMPLETED

Rural MOUD Telemedicine in Primary Care Phase 1

NCT04418453

COMPLETED NA

Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19

NCT04373135

COMPLETED Phase 2

Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19)

NCT04355143

TERMINATED NA

A Pilot Trial of a Network Intervention for Youth After Incarceration

NCT03556618

TERMINATED NA

Digital Behavioral Therapy for Sleep Problems

NCT04308499

COMPLETED NA

Weight Stigma by Association in Parent-Child Dyads

NCT04829162

COMPLETED NA

Helping Families Pilot of a Family Resilience Program for Families Experiencing Homelessness

NCT04273126

COMPLETED NA

Taking Brain Monitoring to the Next Level

NCT04246320

COMPLETED Phase 2

A Novel Human Lab Model for Screening AUD Medications

NCT04249882

COMPLETED NA

Achieving My Potential: A Randomized, Controlled Trial of a Telephone-Based Developmental Care Coordination System

NCT04118452

COMPLETED NA

Electronic Hookah and Endothelial Cell Function

NCT04133376

COMPLETED NA

MBCT and CBT for Youth at High Risk for Mood and Psychotic Disorders: a Randomized Controlled Trial

NCT05070052

COMPLETED NA

Campus Life Study: Harnessing Generativity Among Young Adults

NCT04207528

COMPLETED NA

PEERS© for Careers

NCT04114942

COMPLETED NA

The Effect of Avocado vs. Usual Diet on Skin Aging

NCT05102604

TERMINATED Phase 4

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

NCT04203056

COMPLETED Phase 4

Peri-operative Use of a Pain Injection in Pediatric Patients With Cerebral Palsy

NCT04074265

COMPLETED

Key Dimensions of PTSD and ED

NCT03778307

COMPLETED NA

Mobile Enhanced Prevention Support for People Leaving Jail

NCT04036396

COMPLETED Phase 4

Pudendal Enhancement of Enhanced Recovery After Surgery (ERAS) for Reconstructive Surgery (PEERS)

NCT04171050

COMPLETED NA

Primary Care Clinical Excellence Incentive Study

NCT04237883

TERMINATED NA

Social Engagement Strategies to Improve Medication Adherence

NCT03734887

COMPLETED NA

UC Health Care Planning Study

NCT04012749

COMPLETED NA

Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- RCT 2

NCT04110314

COMPLETED NA

Beacon Sensors and Telerehabilitation for Low Vision

NCT04066075

COMPLETED

Effect of the 3 Wishes Program on Bereaved Families' End-of-Life Care Perceptions

NCT05128799

COMPLETED Phase 1

Sleep and Healthy Aging Research on Depression for Younger Women

NCT03848715

COMPLETED NA

Addressing Obesity in Early Care and Education Settings

NCT04140032

COMPLETED NA

Smoking and Ventricular Repolarization

NCT03916341

COMPLETED NA

Healing Our Hearts Minds and Bodies: CVD Reduction in Persons With HIV

NCT04025463

TERMINATED NA

Nutritional Supplementation in the Elderly With Weight Loss

NCT04350762

COMPLETED NA

Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Testing Kit on Colorectal Cancer Screening Rates

NCT05115916

TERMINATED NA

TMS and Exposure Therapy

NCT04019054

COMPLETED NA

Youth Services Navigation Intervention for HIV+ Youth Being Released From or At-risk for Incarceration

NCT03584932

TERMINATED Phase 2

Maraviroc to Augment Rehabilitation Outcomes After Stroke

NCT03172026

TERMINATED NA

Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke Before and After Thrombectomy

NCT04061577

COMPLETED

Smarter Care Virginia, Examining Low-Value Care in Virginia

NCT04053335

COMPLETED NA

The Effect of a Healthy Snack on Radiance, Aging and Inflammation of the Skin

NCT04352504

COMPLETED NA

Arbitration Between Habitual and Goal-directed Behavior in Obsessive-compulsive Disorder: Circuit Dynamics and Effects of Noninvasive Neurostimulation

NCT04075890

COMPLETED NA

D-CARE - The Dementia Care Study: A Pragmatic Clinical Trial of Health System-Based Versus Community-Based Dementia Care

NCT03786471

COMPLETED NA

Low Intensity Focused Ultrasound for Learning and Memory and Emotion Regulation

NCT03717922

COMPLETED Early Phase 1

Exercise in Methamphetamine Use Disorder Upregulation and Neural Function

NCT03709667

← Previous Page 8 of 18 Next →

Phase Distribution

PhaseTrial count
Phase 1 112
Phase 2 82
Phase 3 22
Phase 4 76

What is open in the University of California, Los Angeles pipeline

158 recruiting of 897 indexed (18% open); 622 completed (69%).

Phase mix: 98 late (III/IV) vs 194 early (I/II) (early-phase heavy).

Top condition: Depression (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of California, Los Angeles: open-pipeline peers nationwide

Peers matched on 897 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 5%10%15%20% Total trials Recruiting share University of California, Los AngelesIndiana UniversityHoffmann-La RocheBrigham and Women's HospitalUniversity of Texas Southwestern Medical CenterConvaTecEndologixNational Institute on Deafness and Other Communication Disorders (NIDCD)NICHD Pelvic Floor Disorders Network
University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 897 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this University of California, Los Angeles page

897 registered trials is a research-attention snapshot, not an endorsement of University of California, Los Angeles or any single study.

  • 158 of University of California, Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of California, Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Los Angeles pipeline card: 897 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.